Cargando…
Nanomicelle-Microsphere Composite as a Drug Carrier to Improve Lung-Targeting Specificity for Lung Cancer
Lung cancer is the second-most common cancer and has the highest mortality among all cancer types. Nanoparticle (NP) drug delivery systems have been used to improve the therapeutic effectiveness of lung cancer, but rapid clearance and poor targeting limit their clinical utility. Here, we developed a...
Autores principales: | Zhang, Qianqian, Bao, Jianwei, Duan, Tijie, Hu, Minxing, He, Yuting, Wang, Junwei, Hu, Rongfeng, Tang, Jihui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955237/ https://www.ncbi.nlm.nih.gov/pubmed/35335884 http://dx.doi.org/10.3390/pharmaceutics14030510 |
Ejemplares similares
-
In Situ Sustained Macrophage-Targeted Nanomicelle–Hydrogel Microspheres for Inhibiting Osteoarthritis
por: Li, XiaoXiao, et al.
Publicado: (2023) -
Nanomicelles loaded with doxorubicin and curcumin for alleviating multidrug resistance in lung cancer
por: Gu, Yue, et al.
Publicado: (2016) -
Gefitinib-loaded DSPE-PEG2000 nanomicelles with CD133 aptamers target lung cancer stem cells
por: Huang, Xiaolong, et al.
Publicado: (2017) -
Development of high drug-loading nanomicelles targeting steroids to the brain
por: Zheng, Sijia, et al.
Publicado: (2013) -
Aminoglucose-functionalized, redox-responsive polymer nanomicelles for overcoming chemoresistance in lung cancer cells
por: Zhou, Yi, et al.
Publicado: (2017)